{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:28:55Z","timestamp":1707524935154},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,27]]},"DOI":"10.7759\/cureus.35541","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T16:36:27Z","timestamp":1677515787000},"source":"Crossref","is-referenced-by-count":0,"title":["Concurrent Splenic Marginal Zone B Cell Lymphoma and Metastatic Pancreatic Adenocarcinoma Diagnosed on Splenectomy for Suspected Splenic Abscess"],"prefix":"10.7759","author":[{"given":"Kamilah","family":"Fernandez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laraine H","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabesan","family":"Balasinkam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lekidelu","family":"Taddesse-Heath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjhh.2016.09.014","article-title":"Splenic marginal zone lymphoma: a literature review of diagnostic and therapeutic challenges","volume":"39","author":"Santos TS","year":"2017","unstructured":"Santos TS, Tavares RS, Farias DL. Splenic marginal zone lymphoma: a literature review of diagnostic and therapeutic challenges. Rev Bras Hematol Hemoter. 2017, 39:146-54. 10.1016\/j.bjhh.2016.09.014","journal-title":"Rev Bras Hematol Hemoter"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-020-02030-3","article-title":"Splenic marginal zone lymphoma: a case report and literature review","volume":"18","author":"Zhang S","year":"2020","unstructured":"Zhang S, Xuan Z, Zhang L, Lu J, Song P, Zheng S. Splenic marginal zone lymphoma: a case report and literature review. World J Surg Oncol. 2020, 18:259. 10.1186\/s12957-020-02030-3","journal-title":"World J Surg Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-624312","article-title":"Splenic marginal zone lymphoma: from genetics to management","volume":"127","author":"Arcaini L","year":"2016","unstructured":"Arcaini L, Rossi D, Paulli M. Splenic marginal zone lymphoma: from genetics to management. Blood. 2016, 127:2072-81. 10.1182\/blood-2015-11-624312","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.21037\/aol-20-28","article-title":"Epidemiology of marginal zone lymphoma","volume":"5","author":"Cerhan JR","year":"2021","unstructured":"Cerhan JR, Habermann TM. Epidemiology of marginal zone lymphoma. Ann Lymphoma. 2021, 5:10.21037\/aol-20-28","journal-title":"Ann Lymphoma"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2005.00578.x","article-title":"Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphoma","volume":"76","author":"Iannitto E","year":"2006","unstructured":"Iannitto E, Minardi V, Callea V, et al.. Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphoma. Eur J Haematol. 2006, 76:134-40. 10.1111\/j.1600-0609.2005.00578.x","journal-title":"Eur J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000455736","article-title":"Pancreatic ductal adenocarcinoma","volume":"26","author":"Dhillon J","year":"2020","unstructured":"Dhillon J, Betancourt M. Pancreatic ductal adenocarcinoma. Monogr Clin Cytol. 2020, 26:74-91. 10.1159\/000455736","journal-title":"Monogr Clin Cytol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.32074\/1591-951X-167","article-title":"Malignant epithelial\/exocrine tumors of the pancreas","volume":"112","author":"Luchini C","year":"2020","unstructured":"Luchini C, Grillo F, Fassan M, et al.. Malignant epithelial\/exocrine tumors of the pancreas. Pathologica. 2020, 112:210-26. 10.32074\/1591-951X-167","journal-title":"Pathologica"},{"key":"ref8","unstructured":"Cancer Stat Facts. Pancreatic cancer. (2022). Accessed: November 7, 2022: https:\/\/seer.cancer.gov\/statfacts\/html\/pancreas.html."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000001762","article-title":"Artificial intelligence and early detection of pancreatic cancer: 2020 summative review","volume":"50","author":"Kenner B","year":"2021","unstructured":"Kenner B, Chari ST, Kelsen D, et al.. Artificial intelligence and early detection of pancreatic cancer: 2020 summative review. Pancreas. 2021, 50:251-79. 10.1097\/MPA.0000000000001762","journal-title":"Pancreas"},{"key":"ref10","unstructured":"SEER Cancer Statistics Review (CSR) 1975-2017. (2020). Accessed. November 7, 2022: https:\/\/seer.cancer.gov\/archive\/csr\/1975_2017\/."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5858\/2008-132-931-MPOCRF","article-title":"Metastatic patterns of cancers: results from a large autopsy study","volume":"132","author":"Disibio G","year":"2008","unstructured":"Disibio G, French SW. Metastatic patterns of cancers: results from a large autopsy study. Arch Pathol Lab Med. 2008, 132:931-9. 10.5858\/2008-132-931-MPOCRF","journal-title":"Arch Pathol Lab Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5858\/2007-131-965-SMCPDD","article-title":"Splenic metastases: clinicopathologic presentation, differential diagnosis, and pathogenesis","volume":"131","author":"Comp\u00e9rat E","year":"2007","unstructured":"Comp\u00e9rat E, Bardier-Dupas A, Camparo P, Capron F, Charlotte F. Splenic metastases: clinicopathologic presentation, differential diagnosis, and pathogenesis. Arch Pathol Lab Med. 2007, 131:965-9. 10.5858\/2007-131-965-SMCPDD","journal-title":"Arch Pathol Lab Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9918154","article-title":"Spontaneous splenic rupture due to metastatic pancreatic cancer","volume":"2021","author":"Politis D","year":"2021","unstructured":"Politis D, Myoteri D, Bourou M, Nastos C, Papaconstantinou I, Dellaportas D. Spontaneous splenic rupture due to metastatic pancreatic cancer. Case Rep Surg. 2021, 2021:9918154. 10.1155\/2021\/9918154","journal-title":"Case Rep Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.0936","article-title":"Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma","volume":"25","author":"Hodgson DC","year":"2007","unstructured":"Hodgson DC, Gilbert ES, Dores GM, et al.. Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol. 2007, 25:1489-97. 10.1200\/JCO.2006.09.0936","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.11.237","article-title":"Thyroid malignancies in survivors of Hodgkin lymphoma","volume":"88","author":"Michaelson EM","year":"2014","unstructured":"Michaelson EM, Chen YH, Silver B, Tishler RB, Marcus KJ, Stevenson MA, Ng AK. Thyroid malignancies in survivors of Hodgkin lymphoma. Int J Radiat Oncol Biol Phys. 2014, 88:636-41. 10.1016\/j.ijrobp.2013.11.237","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910401)67:7<2002::aid-cncr2820670729>3.0.co;2-e","article-title":"Second cancers following non-Hodgkin's lymphoma","volume":"67","author":"Travis LB","year":"1991","unstructured":"Travis LB, Curtis RE, Boice JD Jr, Hankey BF, Fraumeni JF Jr. Second cancers following non-Hodgkin's lymphoma. Cancer. 1991, 67:2002-9. 10.1002\/1097-0142(19910401)67:7&lt;2002::aid-cncr2820670729&gt;3.0.co;2-e","journal-title":"Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-7-9","article-title":"The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-\/20+ phenotype is more specific than CDX2 antibody","volume":"9","author":"Bayrak R","year":"2021","unstructured":"Bayrak R, Haltas H, &amp; Yenidunya S,. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-\/20+ phenotype is more specific than CDX2 antibody. Diagn Pathol . 2021, 9:10.1186\/1746-1596-7-9","journal-title":"Diagn Pathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086853","article-title":"Utilization of CDX2 expression in diagnosing pancreatic ductal adenocarcinoma and predicting prognosis","volume":"9","author":"Xiao W","year":"2014","unstructured":"Xiao W, Hong H, Awadallah A, Zhou L, Xin W. Utilization of CDX2 expression in diagnosing pancreatic ductal adenocarcinoma and predicting prognosis. PLoS One. 2014, 9:e86853. 10.1371\/journal.pone.0086853","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21609","article-title":"Cytokeratin 20 expression identifies a subtype of pancreatic adenocarcinoma with decreased overall survival","volume":"106","author":"Matros E","year":"2006","unstructured":"Matros E, Bailey G, Clancy T, et al.. Cytokeratin 20 expression identifies a subtype of pancreatic adenocarcinoma with decreased overall survival. Cancer. 2006, 106:693-702. 10.1002\/cncr.21609","journal-title":"Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2017.02.359","article-title":"Splenic involvement in pancreatic adenocarcinoma may carry significant clinical impact","volume":"19","author":"Ramanathan K","year":"2017","unstructured":"Ramanathan K, Carr RA, Roch AM, et al.. Splenic involvement in pancreatic adenocarcinoma may carry significant clinical impact. HPB (Oxford). 2017, 19:S161. 10.1016\/j.hpb.2017.02.359","journal-title":"HPB (Oxford)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/139002-concurrent-splenic-marginal-zone-b-cell-lymphoma-and-metastatic-pancreatic-adenocarcinoma-diagnosed-on-splenectomy-for-suspected-splenic-abscess","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:54:04Z","timestamp":1707508444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/139002-concurrent-splenic-marginal-zone-b-cell-lymphoma-and-metastatic-pancreatic-adenocarcinoma-diagnosed-on-splenectomy-for-suspected-splenic-abscess"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.35541","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,27]]}}}